These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34650611)

  • 1. Efficacy of Qingfei Paidu Decoction on Patients with COVID-19 Pneumonia in Wuhan, China: A Propensity Score Matching Study.
    Liu Z; Du S; Shao F; Li H; Xu S; Ma X; Xu Z; Cui H; Yu C; Wu Y; Wang F; Li L; Chen R; Qiu H; Tang Z; Sun P
    Evid Based Complement Alternat Med; 2021; 2021():4303380. PubMed ID: 34650611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment.
    Xin S; Cheng X; Zhu B; Liao X; Yang F; Song L; Shi Y; Guan X; Su R; Wang J; Xing L; Xu X; Jin L; Liu Y; Zhou W; Zhang D; Liang L; Yu Y; Yu R
    Biomed Pharmacother; 2020 Sep; 129():110500. PubMed ID: 32768975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production
    Li Y; Li B; Wang P; Wang Q
    Front Pharmacol; 2021; 12():722126. PubMed ID: 34764867
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy.
    Zhang F; Huang J; Liu W; Wang CR; Liu YF; Tu DZ; Liang XM; Yang L; Zhang WD; Chen HZ; Ge GB
    Food Chem Toxicol; 2021 Mar; 149():111998. PubMed ID: 33476691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of modulating effect of Qingfei Paidu Decoction on host metabolism and gut microbiome in rats].
    Wu GS; Zhong J; Zheng NN; Wang CR; Jin HL; Ge GB; Han JY; Gao Y; Sheng LL; Zhang WD; Li HK
    Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3726-3739. PubMed ID: 32893565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of Qingfei Paidu decoction combined with antiviral drugs in the treatment of corona virus disease 2019: A protocol for systematic review and meta analysis.
    Gao K; Song YP; Chen H; Zhao LT; Ma L
    Medicine (Baltimore); 2020 May; 99(22):e20489. PubMed ID: 32481460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rationality of Asari Radix et Rhizoma in Qingfei Paidu Decoction based on literature analysis].
    Qin ZN; Wang MX; Shi NN; Wang YP; Zhai HQ
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1515-1520. PubMed ID: 32489028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application.
    Ren W; Ma Y; Wang R; Liang P; Sun Q; Pu Q; Dong L; Mazhar M; Luo G; Yang S
    Front Pharmacol; 2020; 11():589714. PubMed ID: 33584265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China.
    Luo E; Zhang D; Luo H; Liu B; Zhao K; Zhao Y; Bian Y; Wang Y
    Chin Med; 2020; 15():34. PubMed ID: 32308732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study.
    Zhang L; Zheng X; Bai X; Wang Q; Chen B; Wang H; Lu J; Hu S; Zhang X; Zhang H; Liu J; Shi Y; Zhou Z; Gan L; Li X; Li J
    Phytomedicine; 2021 May; 85():153531. PubMed ID: 33799224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical profiling of Qingfei Paidu Decoction by triplex off-line two-dimensional liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Shen A; Zhou W; Xiong L; Jin H; Yu L; Wu H; Yu W; Yu D; Guo Z; Liu Y; Liang X
    J Sep Sci; 2022 Mar; 45(6):1162-1169. PubMed ID: 35000274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Effect of Qingfei Paidu Decoction Combined With Conventional Treatment on COVID-19 Patients and Other Respiratory Diseases: A Multi-Center Retrospective Case Series.
    Zong X; Liang N; Wang J; Li H; Wang D; Chen Y; Zhang H; Jiao L; Li A; Wu G; Li J; Wang M; Liu H; Liu Z; Zhao S; Huang J; Huang Q; Wang X; Qin J; Ma Y; Wang Y; Shi N
    Front Pharmacol; 2022; 13():849598. PubMed ID: 35910390
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score-matching analysis.
    Yang Q; Zhou Y; Wang X; Gao S; Xiao Y; Zhang W; Hu Y; Wang Y
    Respir Res; 2020 Jul; 21(1):172. PubMed ID: 32631365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
    Wu C; Chen X; Cai Y; Xia J; Zhou X; Xu S; Huang H; Zhang L; Zhou X; Du C; Zhang Y; Song J; Wang S; Chao Y; Yang Z; Xu J; Zhou X; Chen D; Xiong W; Xu L; Zhou F; Jiang J; Bai C; Zheng J; Song Y
    JAMA Intern Med; 2020 Jul; 180(7):934-943. PubMed ID: 32167524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study.
    Shi N; Liu B; Liang N; Ma Y; Ge Y; Yi H; Wo H; Gu H; Kuang Y; Tang S; Zhao Y; Tong L; Liu S; Zhao C; Chen R; Bai W; Fan Y; Shi Z; Li L; Liu J; Gu H; Zhi Y; Wang Z; Li Y; Li H; Wang J; Jiao L; Tian Y; Xiong Y; Huo R; Zhang X; Bai J; Chen H; Chen L; Feng Q; Guo T; Hou Y; Hu G; Hu X; Hu Y; Huang J; Huang Q; Huang S; Ji L; Jin H; Lei X; Li C; Wu G; Li J; Li M; Li Q; Li X; Liu H; Liu J; Liu Z; Ma Y; Mao Y; Mo L; Na H; Wang J; Song F; Sun S; Wang D; Wang M; Wang X; Wang Y; Wang Y; Wu W; Wu L; Xiao Y; Xie H; Xu H; Xu S; Xue R; Yang C; Yang K; Yang P; Yuan S; Zhang G; Zhang J; Zhang L; Zhao S; Zhao W; Zheng K; Zhou Y; Zhu J; Zhu T; Li G; Wang W; Zhang H; Wang Y; Wang Y
    Pharmacol Res; 2020 Nov; 161():105290. PubMed ID: 33181320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.
    Wang Q; Zhu H; Li M; Liu Y; Lai H; Yang Q; Cao X; Ge L
    Front Pharmacol; 2021; 12():688857. PubMed ID: 34456720
    [No Abstract]   [Full Text] [Related]  

  • 18. Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research.
    Wang J; Qi F
    Drug Discov Ther; 2020; 14(3):149-150. PubMed ID: 32669523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Guo J; Zhou B; Zhu M; Yuan Y; Wang Q; Zhou H; Wang X; Lv T; Li S; Liu P; Yang Y; He P; Zhang P
    Epidemiol Infect; 2020 Oct; 148():e241. PubMed ID: 32998791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of mortality and contribution of treatment in patients infected with COVID-19: a retrospective propensity score matched study.
    Wang Y; Yan X; Huang C; Sun Y; Yao C; Lin Y; Xiao W
    Curr Med Res Opin; 2021 Jan; 37(1):13-19. PubMed ID: 33210547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.